India, July 24 -- Alumis Inc. (ALMS) has completed patient enrollment in its global phase IIb trial of ESK-001 for the treatment of systemic lupus erythematosus, the most common form of lupus. The ph... Read More
India, July 24 -- Norfolk Southern (NSC) and Union Pacific (UNP) confirmed that they are engaged in advanced talks regarding a potential business combination. The companies stated that they do not int... Read More
India, July 24 -- UK private sector output continued to grow in July but the pace of expansion moderated as services activity lost momentum, flash survey results from S&P Global revealed on Thursday. ... Read More
India, July 24 -- Atara Biotherapeutics Inc. (ATRA) is one step closer to securing approval for Tabelecleucel, a first-of-its-kind treatment for patients in the U.S. Tabelecleucel, an innovative allo... Read More
India, July 24 -- Novavax, Inc. (NVAX) Thursday said that its H5N1 avian pandemic influenza vaccine candidate induced robust immune responses in nonhuman primates. Results from the study suggest that... Read More
India, July 24 -- Canadian shares are likely to open on a mixed note Thursday morning with investors focusing on trade talks between Canadian and U.S. officials, and reacting to the latest batch of ec... Read More
India, July 24 -- The euro area private sector grew at the fastest pace in almost a year in July as the recession in the manufacturing sector is coming to an end, flash survey results from S&P Global ... Read More
India, July 24 -- American Airlines Group Inc. (AAL) said it expects a third-quarter adjusted loss per share to be between $0.10 and $0.60. Based on recent booking trends, American expects full-year a... Read More
India, July 24 -- While reporting financial results for the second quarter on Thursday, CTS Corp. (CTS) maintained its adjusted earnings and sales guidance for the full-year 2025. For fiscal 2025, th... Read More
India, July 24 -- The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.10 A.M. ET). In the Green Liminatus Pharma, Inc. (LIMN) is up over 25% at $8.13.Max... Read More